United States Patent: 6562841
ثبت نشده
چکیده
A method for selecting the most effective arthropod repellent from stereoisomers of a compound, involving testing each stereoisomer of the compound for its effectiveness as an arthropod repellent against an arthropod of a particular genus and species, comparing the test results and selecting the most effective arthropod repellent stereoisomer from the stereoisomers of the compound, wherein the compound is a piperidine analog. A composition for repelling arthropods, containing a carrier material and an arthropod repelling effective amount of a stereoisomer of a compound, wherein said stereoisomer is selected by the above method. A method for repelling arthropods (e.g., Aedes aegypti or Aedes albopictus) from a mammal, involving treating the mammal with an arthropod with the above repelling composition (e.g., containing (1S,2'S) stereoisomer of 1-(3-cyclohexen-1-ylcarbonyl)-2-methylpiperidine). Inventors: Klun; Jerome A. (Potomac, MD), Schmidt; Walter F. (Beltsville, MD) Assignee: The United States of America as represented by the Secretary of Agriculture (Washington, DC) Appl. No.: 09/978,154 Filed: October 16, 2001 Current U.S. Class: 514/315 ; 514/330 http://patft.uspto.gov/netacgi/nph-Parser?Sect...f=G&l=50&d=PALL&RefSrch=yes&Query=PN%2F6562841 (1 of 18) [1/23/2007 8:45:53 AM] United States Patent: 6562841 Current International Class: A01N 43/40 (20060101); A01N 43/34 (20060101); G01N 33/50 (20060101) Field of Search: 424/405 514/315,330 References Cited [Referenced By] U.S. Patent Documents 4797408 January 1989 McGovern et al. 5008261 April 1991 Kruger et al.
منابع مشابه
Heart Carcinoid Disease with Patent Foramen Ovale Treated by Mini Sternotomy
This case report was an attempt to present the importance of diagnostic echocardiography and closure of a patent foramen ovale in carcinoid heart disease. Herein, we present a case of a 48-year-old woman with a carcinoid metastasis presenting with tricuspid regurgitation, pulmonic stenosis, patent foramen ovale, and borderline left ventricular ejection fraction on an echocardiogram. Surgical in...
متن کاملترسیم ساختار علمی پروانه های ثبت اختراع حوزه تجهیزات پزشکی و آزمایشگاهی طی سال های 1984 تا 2014 میلادی از سامانه USPTO
Background and Aim: The purpose of this study was to analyze the co-occurrence of the terms of medical and laboratory equipment patents in the United States Patent and Trademark Office between 1984 and 2014. Materials and Methods: This research was an applied study using scientometrics and co-word analyses. The statistical population of the present study included all patents of medical and lab...
متن کاملU.s. Infringement Liability for Foreign Sellers of Infringing Products
IMPORTATION AS AN EXCLUSIVE RIGHT ¶1 Making, selling, or using a U.S.-patented product or process in a foreign country does not infringe the United States patent. United States law cannot govern in other countries, and the patentee’s remedy is therefore dependent on the laws of the relevant foreign country. But when the patented product (or the product of the patented process) is brought into t...
متن کاملMeasuring and Modeling Trans-Border Patent Rewards
Patent rewards in countries with strong patent systems and economies serve as worldwide inducements for technological progress. Due to the national treatment provisions of leading patent laws – requiring that foreign inventors be treated equally with inventors who are citizens of the countries enacting the laws – foreign inventors and companies gain access to patent-mediated market controls and...
متن کاملPatentability of Stem Cells in the United States.
Until recently, the patentability of stem cells was well established within the judicial and statutory framework in the United States. However, the shifting landscape of patent law, particularly with regard to patent-eligible subject matter under 35 U.S.C. §101, presents new challenges to the patentability of stem cells. In this paper, we discuss the legal precedent that paved the way for stem ...
متن کامل